0001437749-19-021587.txt : 20191105 0001437749-19-021587.hdr.sgml : 20191105 20191105160208 ACCESSION NUMBER: 0001437749-19-021587 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191101 FILED AS OF DATE: 20191105 DATE AS OF CHANGE: 20191105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANDBERG RICHARD A CENTRAL INDEX KEY: 0001245055 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 191193215 MAIL ADDRESS: STREET 1: 330 NEVEDA STREET CITY: NEWTON STATE: MA ZIP: 02460-1458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2019-11-01 0001586049 Oxford Immunotec Global PLC OXFD 0001245055 SANDBERG RICHARD A C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Ordinary Shares 2019-11-01 4 M 0 1650 0.09 A 1650 D Ordinary Shares 2019-11-01 4 M 0 1350 8.65 A 3000 D Ordinary Shares 2019-11-01 4 S 0 3000 15.60 D 0 D Stock Option (Right to Buy) 0.09 2019-11-01 4 M 0 1650 0 D 2020-03-31 Ordinary Shares 1650 0 D Stock Option (Right to Buy) 8.65 2019-11-01 4 M 0 1350 0 D 2026-06-28 Ordinary Shares 1350 6107 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017. Exercise from an option granted February 18, 2010, which became fully vested on April 1, 2014. Exercise from an option granted June 28, 2016, which became fully vested on June 6, 2017. /s/ Matthew T E McLaughlin, as Attorney-in-Fact for Richard A. Sandberg 2019-11-05